Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals.
Scharf L, Pedersen CB, Johansson E, Lindman J, Olsen LR, Buggert M, Wilhelmson S, Månsson F, Esbjörnsson J, Biague A, Medstrand P, Norrgren H, Karlsson AC, Jansson M; SWEGUB CORE Group. Scharf L, et al. Among authors: olsen lr. Front Immunol. 2021 Oct 12;12:744530. doi: 10.3389/fimmu.2021.744530. eCollection 2021. Front Immunol. 2021. PMID: 34712231 Free PMC article.
The anatomy of single cell mass cytometry data.
Olsen LR, Leipold MD, Pedersen CB, Maecker HT. Olsen LR, et al. Cytometry A. 2019 Feb;95(2):156-172. doi: 10.1002/cyto.a.23621. Epub 2018 Oct 2. Cytometry A. 2019. PMID: 30277658 Free article. Review.
Getting the Most from Your High-Dimensional Cytometry Data.
Olsen LR, Pedersen CB, Leipold MD, Maecker HT. Olsen LR, et al. Immunity. 2019 Mar 19;50(3):535-536. doi: 10.1016/j.immuni.2019.02.015. Immunity. 2019. PMID: 30893579 Free article. No abstract available.
Analysis of Mass Cytometry Data.
Pedersen CB, Olsen LR. Pedersen CB, et al. Among authors: olsen lr. Methods Mol Biol. 2019;1989:267-279. doi: 10.1007/978-1-4939-9454-0_17. Methods Mol Biol. 2019. PMID: 31077111
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
Jørgensen NG, Klausen U, Grauslund JH, Helleberg C, Aagaard TG, Do TH, Ahmad SM, Olsen LR, Klausen TW, Breinholt MF, Hansen M, Martinenaite E, Met Ö, Svane IM, Knudsen LM, Andersen MH. Jørgensen NG, et al. Among authors: olsen lr. Front Immunol. 2020 Nov 9;11:595035. doi: 10.3389/fimmu.2020.595035. eCollection 2020. Front Immunol. 2020. PMID: 33240282 Free PMC article. Clinical Trial.
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
Braun DA, Street K, Burke KP, Cookmeyer DL, Denize T, Pedersen CB, Gohil SH, Schindler N, Pomerance L, Hirsch L, Bakouny Z, Hou Y, Forman J, Huang T, Li S, Cui A, Keskin DB, Steinharter J, Bouchard G, Sun M, Pimenta EM, Xu W, Mahoney KM, McGregor BA, Hirsch MS, Chang SL, Livak KJ, McDermott DF, Shukla SA, Olsen LR, Signoretti S, Sharpe AH, Irizarry RA, Choueiri TK, Wu CJ. Braun DA, et al. Among authors: olsen lr. Cancer Cell. 2021 May 10;39(5):632-648.e8. doi: 10.1016/j.ccell.2021.02.013. Epub 2021 Mar 11. Cancer Cell. 2021. PMID: 33711273 Free PMC article.
105 results